Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study

Background: Chinese patent medicine is widely used among patients with malignant tumors, and current studies have shown that long-term treatment with Chinese patent medicine is related to improved outcomes of patients. Huisheng Oral Liquid is a kind of Chinese patent medicine with the effects of cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Jia, Kegang, Li, Fang, Zhang, Chenxu, Feng, Gang, Du, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443780/
https://www.ncbi.nlm.nih.gov/pubmed/34539404
http://dx.doi.org/10.3389/fphar.2021.719802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443780/
https://www.ncbi.nlm.nih.gov/pubmed/34539404
http://dx.doi.org/10.3389/fphar.2021.719802

Ejemplares similares